The Else Kröner-Fresenius-Stiftung is the healthcare group’s largest shareholder. EKFS holds 26.33 per cent common shares in Fresenius SE & Co. KGaA stock.
There is no interaction between the foundation’s funding activities and the business activities of the healthcare group. The foundation is a recognised non-profit enterprise and is subject to public regulation of foundations.
In 1912, the Fresenius company started out in a pharmacy in Frankfurt am Main. On the occasion of the 100th anniversary, authors Dr Michael Kamp and Dr Florian Neumann created a brochure looking back at the global group’s history. Impressive pictures depict Fresenius and his company, past and present. www.augustdreesbachverlag.de
Fresenius – a fascinating piece of German economic history! Founded in Frankfurt am Main in 1912, Fresenius has evolved over the decades into a globally-active healthcare group. Today, more than 200,000 people in more than 100 countries work for Fresenius, serving the cause of health. Among other things, the book tells how Dr Eduard Fresenius expanded his Hirsch Apotheke to include production of pharmaceuticals, how he and scientist Paul Ehrlich developed their first products and how the business survived the world wars. The years of economic recovery brought international expansion, and the company entered the field of dialysis technology. New developments in pharmacology and medical technology continued to push Fresenius forward. Expansion through acquisitions facilitated the planning, construction and opening of hospitals. Fresenius’ success would not have been possible without the energy and legacy of Else Kröner, who took over the management of the company after the Second World War, and provided it with a dependable partner in the Else Kröner-Fresenius-Stiftung. It was published by the August Dreesbach Verlag. www.augustdreesbachverlag.de